Neurocrine Biosciences
NBIX
#1395
Rank
NZ$21.79 B
Marketcap
$215.25
Share price
0.52%
Change (1 day)
16.07%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Cash on Hand

Cash on Hand as of September 2024 : NZ$2.10 Billion

According to Neurocrine Biosciences 's latest financial reports the company has NZ$2.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neurocrine Biosciences - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$1.63 B4.69%
2022-12-31NZ$1.55 B49.63%
2021-12-31NZ$1.04 B-6.19%
2020-12-31NZ$1.11 B11.51%
2019-12-31NZ$0.99 B2.6%
2018-12-31NZ$0.97 B33.58%
2017-12-31NZ$0.72 B63.72%
2016-12-31NZ$0.44 B-19.91%
2015-12-31NZ$0.55 B123.98%
2014-12-31NZ$0.24 B39.47%
2013-12-31NZ$0.17 B-15.67%
2012-12-31NZ$0.21 B27.14%
2011-12-31NZ$0.16 B0.59%
2010-12-31NZ$0.16 B123.4%
2009-12-31NZ$73.6 M-46.92%
2008-12-31NZ$0.13 B-40.79%
2007-12-31NZ$0.23 B-9.65%
2006-12-31NZ$0.25 B-35.12%
2005-12-31NZ$0.39 B-5.33%
2004-12-31NZ$0.42 B-39.46%
2003-12-31NZ$0.69 B49.09%
2002-12-31NZ$0.46 B-39.32%
2001-12-31NZ$0.77 B107.37%
2000-12-31NZ$0.37 B113.16%
1999-12-31NZ$0.17 B685.19%
1998-12-31NZ$22.2 M-18.46%
1997-12-31NZ$27.22 M70.23%
1996-12-31NZ$15.99 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$1.38 B-34.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.02 B 43.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$16.32 M-99.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.02 B 186.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.47 B 493.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.04 B 710.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.42 B-79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.74 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA